| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −0.6× | −10.3× | |
| Price / Book | 3.2× | 1.0× | |
| Price / Sales | 2.5× | 273.7× | |
| Price / Free cash flow | −0.6× | −25.6× | |
| EV / EBITDA | −0.6× | −24.4× | |
| Earnings yield | −173.5% | −5.2% | |
| Free cash flow yield | −161.5% | −0.8% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
BRNAS:BRVEBraveheart Bio Inc · 🇺🇸 NAS | $18.54 | −0.89% | $1.67B | −25.5× | −78.6% | — |
KRNAS:KRSAKorsana Biosciences Inc · 🇺🇸 NAS | $32.97 | +1.82% | $1.5B | −418.0× | −38.8% | +1266.2% |
CTNAS:CTYCITY THERAPEUTICS INC · 🇺🇸 NAS | $21.66 | −3.33% | $1.09B | −19.3× | 69.1% | — |
OBNAS:OBXObsidian Therapeutics Inc · 🇺🇸 NAS | $11.55 | −1.87% | $713.48M | 4.9× | 2,275.2% | — |
ATNAS:ATTOAttovia Therapeutics Inc · 🇺🇸 NAS | $14.24 | +3.71% | $650.07M | −10.3× | −40.4% | — |
BLNAS:BLSMBlossomHill Therapeutics Inc · 🇺🇸 NAS | $13.55 | −2.80% | $430.69M | −7.3× | 46.0% | — |
VONAS:VOGXVogenx Inc · 🇺🇸 NAS | $14.75 | +1.51% | $219.11M | −149.3× | 157.3% | — |
BSNAS:BSEMBioStem Technologies, Inc. · 🇺🇸 NAS | $1.94 | −7.18% | $34.63M | −5.7× | −16.8% | −56.7% |
EONAS:EOCNEocene Ltd. · 🇺🇸 NAS | $3.08 | +8.14% | $3.21M | −0.3× | −65.3% | +95.2% |
